Charlie Colquitt

Analysis of Novel Anticoagulants for Atrial Fibrillation – Pharmacokinetics and Pharmacological Considerations

Charlie Colquitt, Jocelyn D. Jones & Sylvia H. Jackson · Cardiology and Angiology: An International Journal · 2014

Atrial Fibrillation (AF) is the most common arrhythmia. AF is a major risk factor for stoke.  Warfarin has been available for more than 60 years and until recently it was the only oral anticoagulant used for the prevention of stroke. Despite the extensive studies and proven effic...